NOVARTIS AG-SPONSORED ADR (NVS) Stock Earnings & Estimates
USA - NYSE:NVS - US66987V1098 - ADR
131.51 USD
+0.08 (+0.06%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.375B -1.36% | 46.66B 7.57% | 51.722B 10.85% | 56.408B 9.06% | 57.843B 2.54% | 59.582B 3.01% | 62.625B 5.11% | 65.079B 3.92% | 67.03B 3.00% | 61.257B -8.61% | 56.233B -8.20% | |
| EBITDA YoY % growth | 17.387B 1.82% | 20.919B 20.31% | 20.919B | 23.381B 11.77% | 23.842B 1.97% | 24.815B 4.08% | 28.251B 13.85% | 29.68B 5.06% | 29.745B 0.22% | 23.232B -21.90% | 20.448B -11.98% | |
| EBIT YoY % growth | 10.206B -6.91% | 12.642B 23.87% | 16.32B 29.09% | 20.971B 28.50% | 21.43B 2.19% | 22.657B 5.73% | 25.244B 11.42% | 26.655B 5.59% | 26.823B 0.63% | 22.88B -14.70% | 20.131B -12.01% | |
| Operating Margin | 23.53% | 27.09% | 31.55% | 37.18% | 37.05% | 38.03% | 40.31% | 40.96% | 40.02% | 37.35% | 35.80% | |
| EPS YoY % growth | 6.20 -2.70% | 6.99 12.75% | 7.91 13.19% | 9.19 16.18% | 9.55 4.00% | 10.34 8.19% | 11.05 6.88% | 11.63 5.22% | 12.02 3.37% | 10.17 -15.35% | 8.81 -13.40% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.31 10.76% | 2.05 2.12% | 2.34 1.51% | 2.26 -7.61% | 2.33 0.99% | 1.99 -2.74% |
| Revenue Q2Q % growth | 14.351B 11.92% | 14.21B 8.04% | 13.127B -0.80% | 13.413B -4.56% | 13.632B -5.01% | 13.398B -5.71% |
| EBITDA Q2Q % growth | 5.129B -41.63% | 4.531B -55.26% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.423B 24.78% | 4.712B 16.09% | 5.472B 14.33% | 5.324B 3.28% | 5.447B 0.44% | 4.66B -1.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.45 22.84% | 2.44 | 0.01 | 0.61% |
| Q1 2025 Q2Q % growth | 2.31 26.67% | 2.17 | 0.14 | 6.59% |
| Q4 2024 Q2Q % growth | 2.00 29.41% | 1.89 | 0.11 | 6.06% |
| Q3 2024 Q2Q % growth | 2.09 12.57% | 2.01 | 0.08 | 3.78% |
| Q2 2024 Q2Q % growth | 1.99 7.65% | 1.93 | 0.06 | 3.24% |
| Q1 2024 Q2Q % growth | 1.82 5.26% | 1.73 | 0.09 | 5.40% |
| Q4 2023 Q2Q % growth | 1.55 0.66% | 1.67 | -0.12 | -7.44% |
| Q3 2023 Q2Q % growth | 1.85 15.82% | 1.78 | 0.07 | 3.88% |
| Q2 2023 Q2Q % growth | 1.85 17.31% | 1.75 | 0.10 | 5.73% |
| Q1 2023 Q2Q % growth | 1.73 17.12% | 1.58 | 0.15 | 9.32% |
| Q4 2022 Q2Q % growth | 1.54 8.57% | 1.45 | 0.09 | 6.28% |
| Q3 2022 Q2Q % growth | 1.60 -7.60% | 1.60 | 0.00 | -0.02% |
| Q2 2022 Q2Q % growth | 1.58 -6.02% | 1.55 | 0.03 | 2.08% |
| Q1 2022 Q2Q % growth | 1.48 -3.95% | 1.49 | -0.01 | -0.62% |
| Q4 2021 Q2Q % growth | 1.42 4.48% | 1.46 | -0.05 | -3.12% |
| Q3 2021 Q2Q % growth | 1.73 12.50% | 1.70 | 0.03 | 1.93% |
| Q2 2021 Q2Q % growth | 1.68 22.06% | 1.59 | 0.09 | 5.67% |
| Q1 2021 Q2Q % growth | 1.54 -2.56% | 1.61 | -0.07 | -4.32% |
| Q4 2020 Q2Q % growth | 1.36 1.52% | 1.42 | -0.06 | -4.21% |
| Q3 2020 Q2Q % growth | 1.54 7.80% | 1.50 | 0.04 | 2.60% |
| Q2 2020 Q2Q % growth | 1.38 1.49% | 1.37 | 0.01 | 0.78% |
| Q1 2020 Q2Q % growth | 1.58 28.93% | 1.44 | 0.14 | 9.89% |
| Q4 2019 Q2Q % growth | 1.34 | 1.34 | -0.01 | -0.40% |
| Q3 2019 Q2Q % growth | 1.43 | 1.39 | 0.04 | 2.86% |
| Q2 2019 Q2Q % growth | 1.36 | 1.26 | 0.09 | 7.40% |
| Q1 2019 Q2Q % growth | 1.23 | 1.18 | 0.04 | 3.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 14.054B 12.32% | 14.465B | -411M | -2.84% |
| Q1 2025 Q2Q % growth | 13.233B 11.87% | 13.384B | -151M | -1.13% |
| Q4 2024 Q2Q % growth | 13.153B 15.14% | 13.051B | 102M | 0.78% |
| Q3 2024 Q2Q % growth | 12.823B 8.84% | 12.994B | -171M | -1.32% |
| Q2 2024 Q2Q % growth | 12.512B -8.15% | 12.61B | -98M | -0.78% |
| Q1 2024 Q2Q % growth | 11.829B 7.08% | 11.709B | 120M | 1.02% |
| Q4 2023 Q2Q % growth | 11.423B 4.99% | 11.996B | -573M | -4.78% |
| Q3 2023 Q2Q % growth | 11.782B 9.26% | 12.001B | -219M | -1.82% |
| Q2 2023 Q2Q % growth | 13.622B -37.26% | 13.518B | 104M | 0.77% |
| Q1 2023 Q2Q % growth | 11.047B -13.79% | 12.877B | -1.83B | -14.21% |
| Q4 2022 Q2Q % growth | 10.88B 135.55% | 13.285B | -2.405B | -18.10% |
| Q3 2022 Q2Q % growth | 10.783B -19.33% | 13.106B | -2.323B | -17.72% |
| Q2 2022 Q2Q % growth | 21.712B 63.32% | 13.109B | 8.603B | 65.63% |
| Q1 2022 Q2Q % growth | 12.814B 0.95% | 12.942B | -128M | -0.99% |
| Q4 2021 Q2Q % growth | 4.619B -64.55% | 13.616B | -8.997B | -66.08% |
| Q3 2021 Q2Q % growth | 13.367B 6.61% | 13.285B | 82M | 0.62% |
| Q2 2021 Q2Q % growth | 13.294B 14.39% | 12.773B | 521M | 4.08% |
| Q1 2021 Q2Q % growth | 12.694B -0.11% | 12.771B | -77M | -0.60% |
| Q4 2020 Q2Q % growth | 13.03B 2.47% | 13.147B | -117M | -0.89% |
| Q3 2020 Q2Q % growth | 12.538B 0.45% | 12.818B | -280M | -2.18% |
| Q2 2020 Q2Q % growth | 11.622B -3.34% | 12.13B | -508M | -4.19% |
| Q1 2020 Q2Q % growth | 12.708B 11.45% | 12.249B | 459M | 3.75% |
| Q4 2019 Q2Q % growth | 12.716B | 12.517B | 199M | 1.59% |
| Q3 2019 Q2Q % growth | 12.482B | 12.065B | 417M | 3.46% |
| Q2 2019 Q2Q % growth | 12.024B | 11.752B | 272M | 2.31% |
| Q1 2019 Q2Q % growth | 11.402B | 11.601B | -199M | -1.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.7% | 5.44% | -0.1% | 5.47% |
| Revenue | 1.38% | 3.5% | 0.09% | 1.72% |